Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I

Blood. 2008 Dec 15;112(13):5241-4. doi: 10.1182/blood-2008-06-165738. Epub 2008 Sep 29.

Abstract

Congenital dyserythropoietic anemia (CDA) is a rare group of red blood cell disorders characterized by ineffective erythropoiesis and increased iron absorption. To determine whether growth differentation factor 15 (GDF15) hyper-expression is associated with the ineffective erythropoiesis and iron-loading complications of CDA type I (CDA I), GDF15 levels and other markers of erythropoiesis and iron overload were studied in blood from 17 CDA I patients. Significantly higher levels of GDF15 were detected among the CDA I patients (10 239 +/- 3049 pg/mL) compared with healthy volunteers (269 +/- 238 pg/mL). In addition, GDF15 correlated significantly with several erythropoietic and iron parameters including Hepcidin-25, Ferritin, and Hepcidin-25/Ferritin ratios. These novel results suggest that CDA I patients express very high levels of serum GDF15, and that GDF15 contributes to the inappropriate suppression of hepcidin with subsequent secondary hemochromatosis.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Anemia, Dyserythropoietic, Congenital / etiology*
  • Antimicrobial Cationic Peptides / blood
  • Biomarkers / blood
  • Case-Control Studies
  • Erythropoiesis
  • Female
  • Ferritins / blood
  • Growth Differentiation Factor 15 / blood*
  • Hepcidins
  • Humans
  • Iron / metabolism
  • Iron Overload
  • Israel
  • Male

Substances

  • Antimicrobial Cationic Peptides
  • Biomarkers
  • Growth Differentiation Factor 15
  • HAMP protein, human
  • Hepcidins
  • Ferritins
  • Iron